Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, June 13, 2024 | Back issues
Courthouse News Service Courthouse News Service

Diet Supplements

Generix Laboratories pushes its weight-loss drug, Leptopril, with false claims that it "alters 'variations in the human generic code' and hastens the body's 'disposition of body fat,'" a class action claims in Los Angeles Superior Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.